Covered recipient · General Payments record
MICHAEL R GALAMBOS
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$5,966.70
- Reported across 323 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $499.00 | 34 |
| Education | $16.07 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $188.81 | 19 |
| Lilly USA, LLC | $100.18 | 5 |
| Janssen Biotech, Inc. | $88.09 | 4 |
| Ipsen Biopharmaceuticals, Inc | $34.28 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $27.28 | 1 |
| Mauna Kea Technologies, Inc. | $23.80 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.19 | 1 |
| Ferring Pharmaceuticals Inc. | $16.37 | 1 |
| Celltrion USA Inc. | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.69 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765110 | CMS |
| ABBVIE INC. | $18.95 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765112 | CMS |
| ABBVIE INC. | $9.37 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765114 | CMS |
| ABBVIE INC. | $3.64 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765116 | CMS |
| ABBVIE INC. | $16.17 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765118 | CMS |
| ABBVIE INC. | $8.90 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765120 | CMS |
| ABBVIE INC. | $12.02 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765122 | CMS |
| ABBVIE INC. | $6.25 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765124 | CMS |
| ABBVIE INC. | $6.43 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765126 | CMS |
| ABBVIE INC. | $15.25 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765128 | CMS |
| ABBVIE INC. | $10.50 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765130 | CMS |
| ABBVIE INC. | $7.49 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765132 | CMS |
| ABBVIE INC. | $19.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765134 | CMS |
| ABBVIE INC. | $11.13 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765136 | CMS |
| ABBVIE INC. | $13.32 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765138 | CMS |
| ABBVIE INC. | $8.71 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765140 | CMS |
| ABBVIE INC. | $8.28 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765142 | CMS |
| ABBVIE INC. | $1.97 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765144 | CMS |
| ABBVIE INC. | $8.74 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103765146 | CMS |
| Celltrion USA Inc. | $16.07 | 06/11/2024 | Education | Undisputed | 01/23/2026 | 1075851445 | CMS |
| Ferring Pharmaceuticals Inc. | $16.37 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137477392 | CMS |
| Intercept Pharmaceuticals, Inc. | $27.28 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113639253 | CMS |
| Ipsen Biopharmaceuticals, Inc | $19.96 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091966674 | CMS |
| Ipsen Biopharmaceuticals, Inc | $14.32 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091966672 | CMS |
| Janssen Biotech, Inc. | $20.30 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078523624 | CMS |
| Janssen Biotech, Inc. | $21.18 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078522705 | CMS |
| Janssen Biotech, Inc. | $25.76 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078523637 | CMS |
| Janssen Biotech, Inc. | $20.85 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078525600 | CMS |
| Lilly USA, LLC | $19.82 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135231604 | CMS |
| Lilly USA, LLC | $24.53 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135222549 | CMS |
| Lilly USA, LLC | $19.47 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135231608 | CMS |
| Lilly USA, LLC | $17.99 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135198384 | CMS |
| Lilly USA, LLC | $18.37 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135198046 | CMS |
| Mauna Kea Technologies, Inc. | $23.80 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151447310 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.19 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137551482 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.